NCT04319783 - Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 2, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Advanced Prostate CarcinomaCancer of ProstatePSACastrate Resistant Prostate Cancer

Interventions

DRUG

Darolutamide

Darolutamide alone

RADIATION

Radiotherapy

Darolutamide + Consolidation Radiotherapy

Trial Locations (16)

2065

GenesisCare North Shore, Saint Leonards

2101

St Vincent's Hospital, Darlinghurst

2220

GenesisCare Hurstville, Hurstville

2298

Calvary Mater Newcastle, Waratah

3002

Peter MacCallum Cancer Centre, Parkville, Melbourne

3021

Western Health, St Albans

3121

Icon Cancer Centre Epworth, Richmond

3128

Peter MacCallum Cancer Centre, Box Hill, Box Hill

3550

Peter MacCallum Cancer Centre, Bendigo, Bendigo

4006

Royal Brisbane and Women's Hospital, Herston

4101

Princess Alexandra Hospital (ROPART), Raymond Terrace

4102

Princess Alexandra Hospital (ROPAIR), Woolloongabba

5000

Royal Adelaide Hospital, Adelaide

6150

GenesisCare Fiona Stanley Hospital, Murdoch

7000

Royal Hobart Hospital, Hobart

168583

National Cancer Centre Singapore, Singapore